• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»Editorial: Why India has gain advantage over COVID-19 pandemic? A lesson till now

Editorial: Why India has gain advantage over COVID-19 pandemic? A lesson till now

0
By Biotech Express on April 20, 2020 Articles, Articles- Editorials, SARS- CoV2 & COVID-19 Updates

Why India has gain advantage over COVID19 pandemic? A lesson till now

by Kamal Pratap Singh and Vaibhav Sharma(PhD, AIIMS)

 

India has gain advantage of not becoming a victim of death-air created by Coronavirus named SARS-CoV2 which has swallowed more than 1.5 million lives as on 20th April 2020. According to one website www.worldometers.com the global death rate per million of population is 12.4 as on April 16 ,which means these many people died out of 1 million (10 lakh) people of global population (7.8 billion). Though the virus originated in China it had hurt many countries with severe damage, among worst Italy has most fatalities reaching to 19 thousand, incidence rate of COVID19 has been recorded highest in USA, Spain, France and now spreading to other countries.

The large credit to this success goes to scientific authorities that are close to leaders and/or themselves are leaders like Dr V K Paul (Member, NITI Aayog, a pediatrician by training etc.) and Dr K Vijayraghavan (Principal Scientific Adviser to the Government of India). The team of more than 30 doctors and scientists are working tirelessly as part of two special groups. According to the sources, the first group, constituted on 18 March, is headed by Niti Aayog member Dr V.K. Paul, it has 20 other members. The other group is co-chaired by Dr Paul and PSA to the PM, Dr K. Vijayraghavan, and has nine other members. In this situation all the team members of these leaders have taken every step very cautiously as it is not an easy task to control 1.3 billion people in their home either Physically or mentally.

Fewer than 600 cases had been confirmed at the time of Modi’s announcement but the decision of shutdown at the very early stage of virus spread gave the edge to India when other countries were suffering from disaster or were preparing. The Indian Scientists’ decision of “Lockdown A.S.A.P’’ now has proved to be the best of all strategies against this deadly virus.

India reported its first case of COVID-19 in Kerala, which rose to three cases by February 3; all were students who had returned from Wuhan, China, later all three recovered. On 4th March a family of 6 patients found positive for CoV, 76 old died due to CoV on 12th March and various cases rose across the country, then govt. of India tried to impose curfew in whole India. The decision was welcome by its citizens and that lead to minimal number of cases.

Surge in number of cases have raised questions like to uplift ban or not and what will be the exit plan. Many cases are arising of conglomerations be it Tablighi Jamaat, Sikh Preacher and recent migration of workers etc.
Govt. called to observe curfew on 21st March and to completely lockdown the unnecessary business on 23rd March 2020. This has proved to be a good strategy to protect world’s second most populated country (1.3 billion people) as the rate of infection and death did not surge like that of Italy, Spain France and now USA.
On March 30 the Centre has set up 11 empowered groups for ensuring a comprehensive and integrated response to the Covid-19 pandemic. These groups have been set up under Disaster Management Act. Out of these 11 empowered groups, nine are headed by Secretary-level officers, two by Member, NITI Aayog, and one by the NITI Aayog CEO.

To contain the virus and sustain livelihood several permissions were given in a timely manner for business of basic communities like food and healthcare. At the same time Govt. has advised to ignore outside visit/contact and sometime forcibly tried to impose them under special circumstances.

Financially, India declared several packages to sustain livelihood and to continue economic activity. On 26th March Finance Minister Nirmala Sitharaman announced a relief package of 1.70 lakhs INR or $23 billion to help fight the Covid-19 outbreak, giving various which include each and every citizen of India that has possible stand in vulnerable situation. . An aid of 17,287 crore was provided to state governments as states seek funds to fight Covid-19 emergency.

Similarly, many ministries who would be helpful for emergencies came forward to help emergency. Ministry of Railways introduced isolation beds inside rail coaches, it made all possible arrangement that would require during emergency transportation either to patients or migrants who have stuck outside their house and are facing crisis.
News media reported for two full days about probable plan of Indian Govt. toward Shutdown. And on 14th April 2020, PM Modi released a statement of extended lockdown till 3rd May and loosing canons from 20th April. However, PM told that this is a decision of all but it had hurt around 94 million Railway ticket holders who in total paid Rs. 1490 crore(https://www.nationalheraldindia.com/national/railways-to-refund-indian-rupee1490-crore-for-cancellation-of-94-lakh-ticket-bookings).

Now call by ‘Lockdown2’ by many media reporters, has been supported and praised.

References:
(https://www.cnbc.com/2020/01/30/india-confirms-first-case-of-the-coronavirus.html)
(https://timesofindia.indiatimes.com/india/toll-crosses-100-tablighi-jamaat-members-account-for-30-of-all-cases/articleshow/75000552.cms?from=mdr)
(https://www.telegraph.co.uk/news/2020/03/28/40000-quarantined-punjab-super-spreader-ignores-government-advice/)
(https://www.narendramodi.in/finance-minister-announces-rs-1-70-lakh-crore-relief-package-under-pradhan-mantri-garib-kalyan-yojana-for-the-poor-to-help-them-fight-the-battle-against-corona-virus-548981)

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Researchers who jumped into the field from distant disciplines published lower impact work, study finds

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.